WHO ICTRP trial
The effect of dill powder on the treatment of type 2 diabetic patients
IRCT20120704010181N12 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20120704010181N12 |
|---|---|
| Public title | The effect of dill powder on the treatment of type 2 diabetic patients |
| Scientific title | Assessment of the effect of dill powder on gastrointestinal symptoms, glycemic control, lipid profile, serum levels of oxidant and Inflammatory markers in type 2 diabetic patients |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | diabetes. Diabetes mellitus;,E10-E14 |
| Interventions | Intervention 1: Dill powder, 1 gram , three capsule per day for 8 weeks. Intervention 2: placebo, 1 gram , three capsule per day for 8 weeks. |
| Registration date | May 12, 2018 |
| Target size | 48 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: